期刊文献+

中晚期鼻咽癌患者CD4^+CD25^+T调节细胞和Th17细胞的免疫病理意义 被引量:5

Immunopathological Significance of CD4^+CD25^+Regulatory T Cells and Th17 Cells in Patients with Intermiddle and Advanced Stage Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨中晚期鼻咽癌患者外周血CD4+CD25+T调节细胞和Th17细胞的免疫病理意义。方法采用流式细胞术、RT-PCR方法检测15例中晚期鼻咽癌患者外周血CD4+CD25+T调节细胞、Th17细胞比例和Foxp3、ROR-γt转录活性,并与10例健康体检者相应指标进行比较,分析其免疫病理意义。结果中晚期鼻咽癌患者外周血CD4+CD25+T调节细胞比例及Foxp3转录活性明显高于健康体检者(P<0.05);而Th17细胞比例及ROR-γt转录活性低于健康体检者(P<0.05)。结论 CD4+CD25+T调节细胞、转录因子Foxp3和Th17细胞比例、转录因子ROR-γt共同构成一个平衡反馈体系,参与中晚期鼻咽癌患者肿瘤微环境中免疫耐受现象的发展及免疫逃逸的发生过程。 Objective To investigate the immunopathological significance of CD4 + CD25 + regulatory T cells and Th17 cells in peripheral blood of the patients with intermiddle and advanced stage nasopharyngeal carcinoma. Meth-ods In this study,15 cases of intermiddle and advanced stage nasopharyngeal carcinoma of the observation group and 10 healthy persons of the control group were included to detect their ratio of CD4 + CD25 + T cells and Th17 cells in the peripheral blood by flow cytometry technique,transcriptional activity of Foxp3 and ROR-γt by RT-PCR procedure. Then,a comparative analysis was made to explore their implications in the immunopathological correlation of nasopharyngeal carcinoma. Results The ratio of CD4 + CD25 + T cells to total CD4 + T cells and transcriptional activity of Foxp3 in the peripheral blood among the patients with intermiddle and advanced stage nasopharyngeal car-cinoma were significantly higher than those in the healthy persons(P &lt; 0. 05). Meanwhile,the ratio of Th17 cells to total CD4 + T cells and transcriptional activity of ROR-γt in the peripheral blood among the patients with intermiddle and advanced stage nasopharyngeal carcinoma was significantly lower than those in the healthy persons(P &lt; 0. 05). Conclusion It may be true that CD4 + CD25 + T cells,transcriptiona regulatory factor Foxp3,and Th17 cells as well as ROR-γt altogether compose of a regulating system in a balance feedback way to evolve the developing process of&amp;nbsp;immune tolerance phenomena in the microtumor enviroment and the implication of immune escape among patients with intermiddle and advanced stage nasopharyngeal carcinoma.
出处 《肿瘤基础与临床》 2014年第2期105-108,共4页 journal of basic and clinical oncology
基金 国家自然科学基金资助项目(编号:30973856) 湖南省中医药管理局科研重点项目(编号:2010007)
关键词 CD4+CD25+T调节细胞 FOXP3 TH17 细胞 鼻咽癌 FOXP3 ROR-γt CD4 + CD25 + regulatory T cells Th17 cells,ROR-γt nasopharyngeal carcinoma
  • 相关文献

参考文献2

二级参考文献43

  • 1Nam JS,Terabe M,Kang MJ,et al.Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17[J].Cancer Res,2008,68(10):3 915-3 923.
  • 2Hinrichs CS,Kaiser A,Paulos CM,et al.Type 17 CD8+T cells display enhanced anti-tumor immunity[J].Blood,2009,114:596-599.
  • 3Bronte V.Th17 and cancer:friends or foes?[J].Blood,2008,112:214.
  • 4Muranski P,Restifo NP.Does IL-17 promote tumor growth?[J].Blood,2009,114:231-232.
  • 5Nurieva R,Yang XO,Chung Y,et al.Cutting edge:in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts[J].J Immunol,2009,182:2 565-2 568.
  • 6Lee YK,Turner H,Maynard CL,et al.Late developmental plasticity in the T helper 17 lineage[J].Immunity,2009,30:92-107.
  • 7Dhodapkar KM,Barbuto S,Matthews P,et al.Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma[J].Blood,2008,112:2 878-2 885.
  • 8Yang XO,Nurieva R,Martinez GJ,et al.Molecular antagonism and plasticity of regulatory and inflammatory T cell programs[J].Immunity,2008,29:44-56.
  • 9Zhou L,Lopes JE,Chong MM,et al.TGF-β-induced FoxP3 inhibits Th17 cell differentiation by antagonizing RORγt function[J].Nature,2008,453:236-241.
  • 10Vooa KS,Wang YH,Santori FR,et al.Identification of IL-17-producing FoxP3+ regulatory T cells in humans[J].P NATL ACAD SCI USA,2009,106(12):4 793-4 798.

共引文献27

同被引文献48

  • 1Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion [ J ]. Science, 2011, 331(624) : 1565-1570. DOI: 10. l126/science. 1203486.
  • 2Chang CS, Chang JH, Hsu NC, et al costimulatory molecules are potential nasopharyngeal carcinoma [ J ]. BMC 10.1186/1471-2407-7-88. Expression of CDS0 and CD86 markers for better survival in Cancer, 2007, 7: 88. DOI:.
  • 3Ren SP, Wang L, Wang H, et al. Gene therapy for human nasopha-ryngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model [ J ]. Cancer Biother Radiopharm, 2008, 23 (5): 591-602. DOI: 10. 1089/ebr. 2007. 0447.
  • 4Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-13 targe- ted cancer therapy[J]. Int J Biol Sci, 2012, 8(7) : 964-978. DOI: 10.7150/ijbs. 4564.
  • 5Hu S, Zhou G, Zhang L, et al. The effects of functional polymor- phisms in the TGF[31 gene on nasopharyngeal carcinoma susceptibili- ty[ J ]. Otolaryngol Head Neck Surg, 2012, 146 (4) : 579-584. DOI : 10.1177/0194599811434890.
  • 6Poh YW, Gan SY, Tan EL. Effects of IL-6, IL-10 and TGF-[3 on the expression of survivin and apoptosis in nasopharyngeal carcinoma TW01 cells[J]. Exp Oncol, 2012, 34(2) : 85-89.
  • 7Flies DB, Sandier BJ, Sznol M, et al. Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy[ J ]. Yale J Biol Med, 2011, 84 (4) : 409-421.
  • 8Chen B J, Chapuy B, Ouyang J, et al. PD-L1 expression is charac- teristic of a subset of aggressive B-cell lymphomas and virus-associa- ted malignancies [ J]. Clin Cancer Res, 2013, 19 ( 13 ) : 3462- 3473. DOI: 10. 1158/1078-0432. CCR-13-0855.
  • 9Seliger B, Quandt D. The expression, function, and clinical rele- vance of B7 family members in cancer[ J]. Cancer Immunol Immu- nother, 2012, 61 (8): 1327-1341. DOI: 10. 1007/s00262-012- 1293-6.
  • 10Loos M, Hedderich DM, Friess H, et al. B7-h3 and its role in anti-.tumor immunity[ J]. Clin Dev Immunol, 2010: 683875. DOI: 10. 1155/2010/683875.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部